Literature DB >> 2744012

Erythropoietic protoporphyria in a child.

M Piotte1, A Hassoun, A Bourlond, G Cornu.   

Abstract

Erythropoietic protoporphyria (EPP), a recently described form of porphyria, often remains unrecognized. We report the case of a 7-year-old girl admitted for investigation of photosensitivity since the age of 18 months without any significant objective cutaneous lesions. Clinical features, quantitative determinations of porphyrins in blood, urine and stools, ferrochelatase activity and cutaneous histopathology helped to confirm the diagnosis of EPP. A familial study was also performed. The clinical, laboratory and genetic characteristics of EPP are reviewed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744012     DOI: 10.1007/bf00441543

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  14 in total

1.  Erythropoietic protoporphyria. A new porphyria syndrome with solar urticaria due to protoporphyrinaemia.

Authors:  I A MAGNUS; A JARRETT; T A PRANKERD; C RIMINGTON
Journal:  Lancet       Date:  1961-08-26       Impact factor: 79.321

2.  [Erythropoietic protoporphyria. Ultrastructure of the basal pericapillary complex in the superficial dermis].

Authors:  C Marcoux; A Bourlond
Journal:  Ann Dermatol Venereol       Date:  1988       Impact factor: 0.777

3.  Erythropoietic protoporphyria showing solar purpura.

Authors:  W Torinuki; T Miura
Journal:  Dermatologica       Date:  1983

4.  Canthaxanthine deposits in the eye.

Authors:  A Rousseau
Journal:  J Am Acad Dermatol       Date:  1983-01       Impact factor: 11.527

Review 5.  Photosensitivity in children.

Authors:  C A Ramsay
Journal:  Pediatr Clin North Am       Date:  1983-08       Impact factor: 3.278

6.  Absence of crystalline retinopathy after long-term therapy with beta-carotene.

Authors:  M B Poh-Fitzpatrick; L G Barbera
Journal:  J Am Acad Dermatol       Date:  1984-07       Impact factor: 11.527

7.  Developmental changes in erythrocyte protoporphyrin: roles of iron deficiency and lead toxicity.

Authors:  R Yip; P R Dallman
Journal:  J Pediatr       Date:  1984-05       Impact factor: 4.406

8.  Effect of hematin administration to patients with protoporphyria and liver disease.

Authors:  J R Bloomer; C A Pierach
Journal:  Hepatology       Date:  1982 Nov-Dec       Impact factor: 17.425

9.  beta-Carotene in the treatment of erythropoietic protoporphyria. A short review.

Authors:  G Krook; B Haeger-Aronsen
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1982

10.  Activation of the complement system in patients with porphyrias after irradiation in vivo.

Authors:  H W Lim; M B Poh-Fitzpatrick; I Gigli
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

View more
  1 in total

1.  Erythropoietic protoporphyria without skin symptoms-you do not always see what they feel.

Authors:  Anne L Y Lecluse; Veronica C M Kuck-Koot; Huib van Weelden; Vigfus Sigurdsson; Ingrid M Russel; Jorge Frank; Suzanne G M A Pasmans
Journal:  Eur J Pediatr       Date:  2007-08-21       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.